Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.

Rai A, Nastoupil LJ, Williams JN, Lipscomb J, Ward KC, Howard DH, Lee D, Flowers CR.

Leuk Lymphoma. 2017 Jul;58(7):1570-1580. doi: 10.1080/10428194.2016.1253836. Epub 2016 Nov 10.

PMID:
27830968
2.

Socioeconomic Factors Are Associated With Readmission After Lobectomy for Early Stage Lung Cancer.

Medbery RL, Gillespie TW, Liu Y, Nickleach DC, Lipscomb J, Sancheti MS, Pickens A, Force SD, Fernandez FG.

Ann Thorac Surg. 2016 Nov;102(5):1660-1667. doi: 10.1016/j.athoracsur.2016.05.060. Epub 2016 Jul 29.

PMID:
27476821
3.

The development and acceptability of symptom management quality improvement reports based on patient-reported data: an overview of methods used in PROSSES.

Troeschel A, Smith T, Castro K, Treiman K, Lipscomb J, McCabe RM, Clauser S, Friedman EL, Hegedus PD, Portier K.

Qual Life Res. 2016 Nov;25(11):2833-2843. Epub 2016 Jun 23.

PMID:
27338811
4.

Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years.

Bian J, Bennett C, Cooper G, D'Alfonso A, Fisher D, Lipscomb J, Qian CN.

J Oncol Pract. 2016 Jun;12(6):e670-80. doi: 10.1200/JOP.2015.009118. Epub 2016 May 17.

PMID:
27189357
5.

Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.

Jegadeesh N, Liu Y, Gillespie T, Fernandez F, Ramalingam S, Mikell J, Lipscomb J, Curran WJ, Higgins KA.

Clin Lung Cancer. 2016 Sep;17(5):398-405. doi: 10.1016/j.cllc.2016.01.007. Epub 2016 Feb 2.

PMID:
26936682
6.

Breast Cancer.

Anderson BO, Lipscomb J, Murillo RH, Thomas DB.

In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 3.

7.

What Predicts an Advanced-Stage Diagnosis of Breast Cancer? Sorting Out the Influence of Method of Detection, Access to Care, and Biologic Factors.

Lipscomb J, Fleming ST, Trentham-Dietz A, Kimmick G, Wu XC, Morris CR, Zhang K, Smith RA, Anderson RT, Sabatino SA; Centers for Disease Control and Prevention National Program of Cancer Registries Patterns of Care Study Group..

Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):613-23. doi: 10.1158/1055-9965.EPI-15-0225. Epub 2016 Jan 27.

8.

Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data Base.

Medbery RL, Gillespie TW, Liu Y, Nickleach DC, Lipscomb J, Sancheti MS, Pickens A, Force SD, Fernandez FG.

J Thorac Oncol. 2016 Feb;11(2):222-33. doi: 10.1016/j.jtho.2015.10.007. Epub 2016 Jan 11.

9.

The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it.

Smith TG, Castro KM, Troeschel AN, Arora NK, Lipscomb J, Jones SM, Treiman KA, Hobbs C, McCabe RM, Clauser SB.

Cancer. 2016 Feb 1;122(3):344-51. doi: 10.1002/cncr.29767. Epub 2015 Nov 30.

10.

Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.

Denu RA, Hampton JM, Currey A, Anderson RT, Cress RD, Fleming ST, Lipscomb J, Sabatino SA, Wu XC, Wilson JF, Trentham-Dietz A.

Cancer Epidemiol. 2016 Feb;40:7-14. doi: 10.1016/j.canep.2015.11.003. Epub 2015 Nov 21.

11.

Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition.

Gelband H, Sankaranarayanan R, Gauvreau CL, Horton S, Anderson BO, Bray F, Cleary J, Dare AJ, Denny L, Gospodarowicz MK, Gupta S, Howard SC, Jaffray DA, Knaul F, Levin C, Rabeneck L, Rajaraman P, Sullivan T, Trimble EL, Jha P; Disease Control Priorities-3 Cancer Author Group..

Lancet. 2016 May 21;387(10033):2133-44. doi: 10.1016/S0140-6736(15)00755-2. Epub 2015 Nov 11. Review.

PMID:
26578033
12.

Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.

Khullar OV, Liu Y, Gillespie T, Higgins KA, Ramalingam S, Lipscomb J, Fernandez FG.

J Thorac Oncol. 2015 Nov;10(11):1625-33. doi: 10.1097/JTO.0000000000000664.

13.

Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.

Nanda RH, Liu Y, Gillespie TW, Mikell JL, Ramalingam SS, Fernandez FG, Curran WJ, Lipscomb J, Higgins KA.

Cancer. 2015 Dec 1;121(23):4222-30. doi: 10.1002/cncr.29640. Epub 2015 Sep 8.

14.

Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, Ramalingam SS, Khuri FR, Flowers CR.

JAMA Oncol. 2015 Dec;1(9):1293-300. doi: 10.1001/jamaoncol.2015.3316.

PMID:
26313558
15.

Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer.

Goldstein DA, Ahmad BB, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR.

J Clin Oncol. 2015 Nov 10;33(32):3727-32. doi: 10.1200/JCO.2015.61.9569. Epub 2015 Aug 24.

16.

Nonclinical Factors Associated with 30-Day Mortality after Lung Cancer Resection: An Analysis of 215,000 Patients Using the National Cancer Data Base.

Melvan JN, Sancheti MS, Gillespie T, Nickleach DC, Liu Y, Higgins K, Ramalingam S, Lipscomb J, Fernandez FG.

J Am Coll Surg. 2015 Aug;221(2):550-63. doi: 10.1016/j.jamcollsurg.2015.03.056. Epub 2015 Apr 16.

17.

Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice.

Cohn DE, Havrilesky LJ, Osann K, Lipscomb J, Hsieh S, Walker JL, Wright AA, Alvarez RD, Karlan BY, Bristow RE, DiSilvestro PA, Wakabayashi MT, Morgan R, Mukamel DB, Wenzel L.

Gynecol Oncol. 2015 Sep;138(3):712-6. doi: 10.1016/j.ygyno.2015.07.014. Epub 2015 Jul 12.

18.

Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyond.

Hiatt RA, Tai CG, Blayney DW, Deapen D, Hogarth M, Kizer KW, Lipscomb J, Malin J, Phillips SK, Santa J, Schrag D.

J Natl Cancer Inst. 2015 Mar 11;107(5). pii: djv047. doi: 10.1093/jnci/djv047.

PMID:
25766400
19.

Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer.

Quek RG, Ward KC, Master VA, Lin CC, Portier KM, Virgo KS, Lipscomb J.

J Natl Compr Canc Netw. 2015 Mar;13(3):303-9.

PMID:
25736007
20.

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis.

Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR.

J Clin Oncol. 2015 Apr 1;33(10):1112-8. doi: 10.1200/JCO.2014.58.4904. Epub 2015 Feb 17.

Supplemental Content

Loading ...
Support Center